Kimberly M Thompson

Summary

Publications

  1. doi request reprint Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses
    Kimberly M Thompson
    Kid Risk, Inc, Orlando, FL, USA University of Central Florida, College of Medicine, Orlando, FL, USA Electronic address
    Vaccine 33:1568-77. 2015
  2. doi request reprint Preeradication vaccine policy options for poliovirus infection and disease control
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32832, USA
    Risk Anal 33:516-43. 2013
  3. doi request reprint Modeling population immunity to support efforts to end the transmission of live polioviruses
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32832, USA
    Risk Anal 33:647-63. 2013
  4. doi request reprint Modeling poliovirus risks and the legacy of polio eradication
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32827, USA
    Risk Anal 33:505-15. 2013
  5. doi request reprint Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Road, Suite 204 364, Orlando, FL 32832, USA
    Vaccine 31:B149-56. 2013
  6. doi request reprint Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation
    Kimberly M Thompson
    Kid Risk, Inc, Newton, MA, USA
    Expert Rev Vaccines 11:449-59. 2012
  7. pmc Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response
    Kimberly M Thompson
    Kid Risk, Inc, Newton, MA 02459, USA
    Public Health Rep 127:23-37. 2012
  8. doi request reprint Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs
    Radboud J Duintjer Tebbens
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32832, USA
    Risk Anal 33:606-46. 2013
  9. doi request reprint Economic analysis of the global polio eradication initiative
    Radboud J Duintjer Tebbens
    Kid Risk, Inc, P O Box 590129, Newton, MA 02459, USA
    Vaccine 29:334-43. 2010
  10. ncbi request reprint Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication
    Radboud J Duintjer Tebbens
    Kids Risk Project, Harvard School of Public Health, Boston, MA, USA
    Risk Anal 26:1471-505. 2006

Collaborators

Detail Information

Publications21

  1. doi request reprint Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses
    Kimberly M Thompson
    Kid Risk, Inc, Orlando, FL, USA University of Central Florida, College of Medicine, Orlando, FL, USA Electronic address
    Vaccine 33:1568-77. 2015
    ..Countries currently using a sequential IPV/OPV schedule should continue to use all licensed OPV serotypes until global OPV cessation to minimize vulnerability to circulation of imported polioviruses. ..
  2. doi request reprint Preeradication vaccine policy options for poliovirus infection and disease control
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32832, USA
    Risk Anal 33:516-43. 2013
    ....
  3. doi request reprint Modeling population immunity to support efforts to end the transmission of live polioviruses
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32832, USA
    Risk Anal 33:647-63. 2013
    ..We suggest that dynamically modeling risk represents an essential tool as the number of cases approaches zero...
  4. doi request reprint Modeling poliovirus risks and the legacy of polio eradication
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32827, USA
    Risk Anal 33:505-15. 2013
    ..Following an overview of the contents of the special issue, the introduction explores the road ahead and offers perspective on the legacy of polio eradication...
  5. doi request reprint Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Road, Suite 204 364, Orlando, FL 32832, USA
    Vaccine 31:B149-56. 2013
    ....
  6. doi request reprint Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation
    Kimberly M Thompson
    Kid Risk, Inc, Newton, MA, USA
    Expert Rev Vaccines 11:449-59. 2012
    ....
  7. pmc Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response
    Kimberly M Thompson
    Kid Risk, Inc, Newton, MA 02459, USA
    Public Health Rep 127:23-37. 2012
    ..We evaluated the risk of a U.S. polio outbreak and explored potential vaccine needs for outbreak response...
  8. doi request reprint Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs
    Radboud J Duintjer Tebbens
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32832, USA
    Risk Anal 33:606-46. 2013
    ..This assessment of current knowledge supports the immediate conduct of additional studies to address the gaps...
  9. doi request reprint Economic analysis of the global polio eradication initiative
    Radboud J Duintjer Tebbens
    Kid Risk, Inc, P O Box 590129, Newton, MA 02459, USA
    Vaccine 29:334-43. 2010
    ..This study finds a strong economic justification for the GPEI despite the rising costs of the initiative...
  10. ncbi request reprint Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication
    Radboud J Duintjer Tebbens
    Kids Risk Project, Harvard School of Public Health, Boston, MA, USA
    Risk Anal 26:1471-505. 2006
    ..This article attempts to comprehensively characterize the risks, synthesize the existing data available for modeling them, and present quantitative risk estimates that can provide a starting point for informing policy decisions...
  11. doi request reprint Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses
    Radboud J Duintjer Tebbens
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32832, USA
    Risk Anal 33:703-49. 2013
    ..Broad application of the model promises to offer insights in the context of global and national policy and economic models...
  12. doi request reprint Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs)
    Radboud J Duintjer Tebbens
    Kid Risk, Inc, 10524 Moss Park Rd, Ste, 204 364, Orlando, FL 32832, USA
    Risk Anal 33:680-702. 2013
    ....
  13. doi request reprint Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination
    Dominika A Kalkowska
    Kid Risk, Inc, 10524 Moss Park Road, Site 204 364, Orlando, FL, 32832, USA
    BMC Infect Dis 15:791. 2015
    ....
  14. pmc The potential impact of expanding target age groups for polio immunization campaigns
    Radboud J Duintjer Tebbens
    Kid Risk, Inc, 10524 Moss Park Road, Site 204 364, Orlando, FL 32832, USA
    BMC Infect Dis 14:45. 2014
    ..We explore the potential role of including older children and adults in supplemental immunization activities (SIAs) to more rapidly increase population immunity and prevent or stop transmission...
  15. doi request reprint The probability of undetected wild poliovirus circulation after apparent global interruption of transmission
    Dominika A Kalkowska
    Kid Risk, Inc, Newton, Massachusetts, USA
    Am J Epidemiol 175:936-49. 2012
    ....
  16. doi request reprint Expert review on poliovirus immunity and transmission
    Radboud J Duintjer Tebbens
    Kid Risk, Inc, P O Box 590129, Newton, MA, USA
    Risk Anal 33:544-605. 2013
    ..Given the limitations in the evidence, we identify the need for expert input to derive quantitative model inputs from the existing data...
  17. doi request reprint Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria
    Dominika A Kalkowska
    Kid Risk, Inc, Orlando, Florida Delft University of Technology, Delft, The Netherlands
    J Infect Dis 210:S412-23. 2014
    ..Nigeria continues to struggle in its efforts to eliminate circulating live polioviruses using oral poliovirus vaccine (OPV)...
  18. doi request reprint Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India
    Dominika A Kalkowska
    Kid Risk, Inc, Orlando, Florida Delft University of Technology, Delft, The Netherlands and
    J Infect Dis 210:S398-411. 2014
    ....
  19. doi request reprint Modeling the dynamics of oral poliovirus vaccine cessation
    Kimberly M Thompson
    Kid Risk, Inc College of Medicine, University of Central Florida, Orlando
    J Infect Dis 210:S475-84. 2014
    ..This motivates globally coordinated OPV cessation after wild poliovirus eradication...
  20. doi request reprint Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation
    Radboud J Duintjer Tebbens
    Kid Risk, Inc
    J Infect Dis 210:S485-97. 2014
    ..Stakeholders continue to discuss the role of using inactivated poliovirus vaccine (IPV) to manage the risks of circulating vaccine-derived polioviruses (cVDPVs) during the end game...
  21. doi request reprint National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication
    Kimberly M Thompson
    Kid Risk, Inc, 10524 Moss Park Rd, Ste 204 364, Orlando, FL 32832, USA
    Expert Rev Vaccines 13:221-34. 2014
    ..IPV costs and potential wastage will represent an important consideration for national policy makers. Innovations may reduce future IPV costs, but the world urgently needs lower-cost IPV options. ..